ロード中...
Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1
BACKGROUND: Metformin is the most commonly used first-line medicine for type II diabetes mellitus. Acting via AMP-activated protein kinase, it has been used for more than 60 years and has an outstanding safety record. Metformin also offers protection against cancer, but its precise mechanisms remain...
保存先:
| 出版年: | J Biomed Sci |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6238313/ https://ncbi.nlm.nih.gov/pubmed/30442142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-018-0478-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|